Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Markets & Finance

CS First Boston Cuts Applera-Applied Biosystems Rating


CS First Boston downgraded Applera-Applied Biosystems (ABI) to hold from buy.

Analyst Meirav Chovav says she's concerned over the biotech instrument maker's ability to deliver on top-line and bottom-line growth targets. She notes her $422 million Q4 revenue estimate and $0.24 EPS estimate are below the company's guidance and consensus, but she's concerned there could still be a downside. She notes the company says its 10%-13% projected revenue growth over the next several quarters may be adversely impacted as major foreign currencies have continued to a decline.

Chovav is concerned about a slowdown in mass spectrometer orders, and continued weakness in the DNA-sequence analysis market. She sees $0.95 2001 EPS, and $1.08 EPS for 2002.


The Aging of Abercrombie & Fitch
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus